AMA’s Stance on Transgender Surgery for Minors Sparks Debate & Political Pressure

Recent statements from the American Medical Association (AMA) and the American Society of Plastic Surgeons (ASPS) regarding gender-affirming surgeries for minors have sparked debate and, in some cases, misinterpretation. While neither organization has fundamentally altered its support for evidence-based gender-affirming care, their nuanced positions have been seized upon by both conservative commentators and advocates for transgender rights, highlighting the politically charged environment surrounding care for transgender youth.

On February 4, 2026, the ASPS issued a position statement recommending that gender-affirming surgeries – including chest, genital, and facial procedures – be delayed until a patient is at least 19 years old. The AMA subsequently responded to inquiries by stating that, “in the absence of clear evidence,” it agrees with the ASPS recommendation to generally defer surgical interventions in minors to adulthood. This statement, which was initially shared on the social media platform X (formerly Twitter) and not formally published on the AMA’s website, has been interpreted by some as a retreat from previous support for gender-affirming care.

However, experts emphasize that the AMA’s statement is more of a clarification than a reversal of its position. The AMA continues to support evidence-based treatment, including gender-affirming care, and maintains that gender-affirming medication and surgery are medically necessary when determined through shared decision-making between patient and physician. The organization’s recent comment underscores the current lack of robust evidence specifically supporting surgical interventions in minors, rather than rejecting the broader concept of gender-affirming care.

“If the AMA was wrong about surgeries, could it also have been wrong about hormones?” questioned Leor Sapir, a political scientist and co-author of a recent federal report on gender dysphoria, in a post on X. This sentiment reflects a broader concern among some that questioning the efficacy of surgical interventions might lead to scrutiny of other aspects of gender-affirming care.

The context surrounding these statements is crucial. The current political climate, particularly under the Trump administration, has seen increased efforts to restrict medical care for transgender youth. Proposed rules that would withhold federal funding from hospitals providing gender-affirming care, along with subpoenas and threats of federal investigation, are creating a chilling effect on healthcare providers. According to Hannah Oliason, an attorney specializing in healthcare law, these actions are a far greater concern for hospitals and providers than the ASPS and AMA statements.

Around a dozen hospitals nationwide have already ceased performing surgical procedures on young people due to this federal pressure, as reported on February 5, 2026. This trend underscores the significant impact of the political environment on access to care.

It’s important to note that gender-affirming surgeries are relatively rare among minors. A study found that between 2016 and 2020, approximately 3,200 individuals aged 18 and under underwent top surgery (breast augmentation, reduction, or removal). Fewer than 760 received any other gender-affirming procedure during the same period. This data highlights that the debate surrounding these procedures affects a relatively small number of young people.

Kellan Baker, a senior advisor for health policy at the Movement Advancement Project, suggests that the ASPS and AMA statements may be a response to the pressures of the current political landscape. “I see what ASPS and AMA have put out as clarifications of long-standing principles of the standard of care in an environment where many of their members are likely looking at them and saying, ‘We don’t understand exactly what the Trump administration is doing. How do we try to make sure that we don’t end up in its crosshairs?’”

The potential impact of these statements extends beyond direct clinical practice. Experts suggest they could influence how individual providers assess the risk of potential medical malpractice lawsuits. Carmel Shachar, director of the Health Law and Policy Clinic at Harvard Law School, noted that the AMA’s apparent shift in emphasis could be considered by a jury in such a case.

However, clinical guidance remains the most authoritative factor in medical decision-making. Organizations like the American Academy of Pediatrics continue to support a case-by-case approach to surgery for minors, emphasizing that decisions should be made collaboratively between patients, families, and physicians. The World Professional Association for Transgender Health (WPATH) outlines eight specific requirements that must be met before recommending surgical treatment for individuals under the age of 18, including thorough diagnostic criteria and assessment of mental health.

The Society for Evidence-Based Gender Medicine, a group that critically examines the evidence surrounding gender-affirming care, has indicated that it will continue its scrutiny, even suggesting that the ASPS assessment of evidence might warrant caution for patients in their 20s as well.

the recent statements from the AMA and ASPS reflect a complex interplay of medical considerations, political pressures, and evolving scientific understanding. While the organizations have clarified their positions, the broader debate surrounding gender-affirming care for minors remains highly charged and is likely to continue shaping healthcare policy and practice in the coming years.